Loading...
Reimbursement Cuts Will Hinder Prospects Even As Device Uptake Persists
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
-38.7%7D
-6.3%1Y
-38.7%7D
-6.3%You can edit this narrative until Aug 10 10:54 PM. Then, changes will post as Updates.
You can edit this narrative until Aug 10 10:54 PM. Then, changes will post as Updates.